Literature DB >> 1820639

Pharmacokinetics of primaquine in healthy volunteers.

V Singhasivanon1, A Sabcharoen, P Attanath, T Chongsuphajaisiddhi, B Diquet, P Turk.   

Abstract

The pharmacokinetics of primaquine were investigated in 8 healthy subjects (4 males and 4 females). The volunteers received 15 mg base of primaquine daily for 14 days. The results showed that the concentration-time profiles in whole blood and in plasma were similar. The mean values (+/- SD) of area under the curve (AUC) of the last dose were significantly decreased when compared to the values of the first dose both in whole blood and in plasma (909.96 +/- 603.07, 1,147.05 +/- 684.8 ng.hr/ml respectively in whole blood with p = 0.007 and 1,255.11 +/- 531.59, 1,603.66 +/- 505.45 ng.hr/ml respectively in plasma with p = 0.023). The decrease in the concentration-time profile of the last dose was due to enhancement of drug elimination with significant increase in clearance after the last dose (4.871 +/- 1.741 and 6.443 +/- 2.514 ml/min/kg respectively in whole blood with p = 0.007, 3.199 +/- 1.197 and 4.422 +/- 2.068 ml/min/kg respectively in plasma with p = 0.016).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1820639

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?

Authors:  Bui Tri Cuong; Vu Quoc Binh; Bui Dai; Dinh Ngoc Duy; Claire M Lovell; Karl H Rieckmann; Michael D Edstein
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

Review 2.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to Plasmodium vivax in the Brazilian Amazon Basin.

Authors:  José Luiz Vieira; Michelle E S Ferreira; Michelle V D Ferreira; Margarete M Gomes
Journal:  Am J Trop Med Hyg       Date:  2017-04-05       Impact factor: 2.345

4.  Pharmacokinetic interactions between primaquine and chloroquine.

Authors:  Sasithon Pukrittayakamee; Joel Tarning; Podjanee Jittamala; Prakaykaew Charunwatthana; Saranath Lawpoolsri; Sue J Lee; Warunee Hanpithakpong; Borimas Hanboonkunupakarn; Nicholas P J Day; Elizabeth A Ashley; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

5.  Factors Affecting Primaquine Combination Treatment in Malaria Patients in Selangor, Malaysia.

Authors:  Norliza Mat Ariffin; Farida Islahudin; Mohd Makmor-Bakry; Endang Kumolosasi; Mohd Hafizi A Hamid
Journal:  J Pharm Bioallied Sci       Date:  2017 Oct-Dec

6.  Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin.

Authors:  Amanda Gabryelle Nunes Cardoso Mello; Michelle Valéria Dias Ferreira Vieira; Luann Wendel Pereira de Sena; Thiago Portal da Paixão; Ana Carla Godinho Pinto; Daniella Paternostro de Araújo Grisólia; Margareth Tavares Silva; José Luiz Fernandes Vieira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-10-25       Impact factor: 1.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.